Preferred Label : eliglustat;

MeSH note : a potent inhibitor of glucosylceramide synthase;

CISMeF synonym : Genz-112638;

MeSH Related Number : N0493335P3;

Is substance : O;

UNII : DR40J4WA67;

InChIKey : FJZZPCZKBUKGGU-AUSIDOKSSA-N;

Details


Main resources

You can consult :


https://ansm.sante.fr/tableau-marr/eliglustat
2023
false
false
false
France
French
risk management
eliglustat
guidelines for drug use
drug interactions

---
eliglustat
https://www.ema.europa.eu/medicines/human/EPAR/Cerdelga
2015
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
eliglustat
eliglustat
eliglustat
drug approval
europe
gaucher disease, type 1
adult
orphan drug production
rare diseases
administration, oral
enzyme inhibitors
enzyme inhibitors
drug monitoring
risk management
product surveillance, postmarketing
drug interactions
breast feeding
pregnancy
ceramide glucosyltransferase
drug evaluation, preclinical
gaucher disease
pyrrolidines
pyrrolidines
glucosyltransferases

---
http://www.has-sante.fr/portail/jcms/c_2572136/fr/cerdelga
2015
false
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
administration, oral
eliglustat tartrate
eliglustat tartrate
eliglustat
gaucher disease, type 1
enzyme inhibitors
enzyme inhibitors
adult
orphan drug production
CYP2D6 gene status assay
cytochrome p-450 cyp2d6
ceramide glucosyltransferase
risk management
gaucher disease
eliglustat
eliglustat
gaucher disease
pyrrolidines
pyrrolidines
glucosyltransferases

---
Nous contacter.
25/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.